Why the study?
Does a pharmacoinvasive strategy combining thrombolysis and liberal PCI yield comparable survival rates to primary PCI in patients with STEMI?
Does a pharmacoinvasive strategy combining thrombolysis and liberal PCI yield comparable survival rates to primary PCI in patients with STEMI?
Answers are grounded in this paper and cite their sources.
A pharmacoinvasive strategy combining thrombolysis with liberal PCI provides comparable early and 1-year survival to primary PCI for STEMI patients treated early.
When used early after the onset of symptoms, a pharmacoinvasive strategy that combines thrombolysis with a liberal use of PCI yields early and 1-year survival rates that are comparable to those of PPCI.
No takes yet. Share an insight, caveat, or question.
Danchin et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: